HBV life cycle and novel drug targets

ISSN： 1936-0533

Source： Hepatology International, Vol.5, Iss.2, 2011-06, pp. : 644-653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cathepsins: novel drug targets for cardiovascular diseases?

By Shi Guo-Ping

Future Cardiology, Vol. 1, Iss. 5, 2005-09 ,pp. : 563-565

Future Medicine

Access to resources Recommend Favorite

The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets

Digestive Diseases, Vol. 32, Iss. 5, 2014-07 ,pp. : 525-537

Karger

Access to resources Recommend Favorite

A Mini-Review of Recent W.O. Patents (2004-2005) of Novel Anti-fungal Compounds in the Field of Anti-infective Drug Targets

Recent Patents on Anti-Infective Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 225-230

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of HBV Among HBV/HIV-1 Co-Infected Injecting Drug Users from Mombasa, Kenya

Current HIV Research, Vol. 13, Iss. 4, 2015-07 ,pp. : 292-299

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Drug-Induced Pulmonary Complications in Cancer Patients You Can Save Life!

Current Respiratory Medicine Reviews, Vol. 12, Iss. 2, 2016-07 ,pp. : 157-166

Bentham Science Publishers

Access to resources Recommend Favorite